BioPharma Targets

Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.

PatentsGlobal

Can-Fite BioPharma Targets Global Licensing and Strategic Partnerships at BIO-Europe 2026 After Key Clinical and Patent Advances

Can-Fite BioPharma Ltd. announced its participation in BIO-Europe 2026, leveraging recent clinical milestones and expanded patent protections to pursue licensing and strategic partnerships. The company highlighted positive Phase IIa results in pancreatic cancer, ongoing Phase III trials in liver cancer and psoriasis,…

Friday, November 6, 2026

Newsletters & Digests

Follow BioPharma Targets

Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.

Explore

All coverage Filtered archive